The National Institutes of Health (NIH) is a leading biomedical research facility in the United States, operating under the Department of Health and Human Services. Established in 1887 and based in Bethesda, Maryland, NIH is the primary agency responsible for biomedical and health-related research in the country. It comprises 27 separate institutes and centers, each focusing on different disciplines within biomedical science. NIH conducts its own scientific research through the Intramural Research Program and provides significant funding for research at external institutions via the Extramural Research Program. With a workforce that includes 1,200 principal investigators and over 4,000 postdoctoral fellows, NIH has been instrumental in major medical breakthroughs, such as the development of vaccines for hepatitis and human papillomavirus, as well as the discovery of treatments for various health conditions. As the world's largest source of medical research funding, NIH continues to advance scientific knowledge and contribute to public health improvements.

General Catalyst is a venture capital firm established in 2000, headquartered in Cambridge, Massachusetts, with additional offices in North America and Europe. The company specializes in early-stage and growth equity investments, focusing on technology-driven businesses. It invests across various sectors, including consumer internet, enterprise software, fintech, health assurance, and crypto. General Catalyst provides not only capital but also mentorship and resources to accelerate the growth of its portfolio companies. To date, it has managed eight venture capital funds, totaling approximately $3.75 billion in capital commitments.

MassChallenge is a global nonprofit startup accelerator headquartered in Boston, Massachusetts, established in 2009. It supports early-stage entrepreneurs across various industries, including technology, healthcare, and social impact, by providing mentorship, resources, and networking opportunities. With locations in Israel, Mexico, Switzerland, Texas, and the UK, MassChallenge connects high-potential startups with industry experts and investors to foster innovation and facilitate growth. The accelerator operates on a non-equity model, allowing entrepreneurs to maintain full ownership of their companies while benefiting from strategic partnerships and tailored training programs. Through its diverse initiatives, such as targeted accelerator programs like MassChallenge HealthTech and FinTech, the organization aims to drive impactful change and enhance the global innovation ecosystem.

Alumni Ventures Group, LLC is a venture capital firm based in Manchester, New Hampshire, founded in 2013. The firm specializes in seed and early-stage investments, as well as late-stage pre-IPO opportunities, with a flexible approach that is sector and geographic agnostic. Alumni Ventures aims to provide high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who may not have had access to venture capital previously. The firm focuses on backing companies that have an alumni connection and are led by established institutional investors with expertise in their respective fields. Additionally, Alumni Ventures offers focused funds that enable accredited investors to access a diverse portfolio of investments across various types, sectors, stages, and geographies.

Google.org is a philanthropic arm of Google, a multinational technology company. It funds and supports nonprofits globally, providing them with funding, tools, and volunteers. Google.org has committed approximately $100 million annually to these efforts, aiming to extend the reach of innovative nonprofits and create lasting global impact.

OrbiMed is a healthcare-focused investment firm based in New York City, established in 1989. The firm specializes in providing a range of financing solutions, including bridge loans, senior debt, and structured debt capital for both commercial-stage public and private healthcare companies. OrbiMed invests across various sectors within the healthcare industry, such as pharmaceuticals, life sciences, digital health, medical devices, biopharmaceuticals, diagnostics, healthcare technology, and biotechnology. With approximately $5 billion in assets under management, OrbiMed aims to support a spectrum of healthcare companies, from early-stage ventures to established multinational corporations.

The National Science Foundation (NSF) is an independent federal agency established in 1950 and based in Alexandria, Virginia. It is dedicated to supporting research and education in science and engineering across a wide range of disciplines. The NSF provides significant non-dilutive funding, up to $1.5 million, to startups and small businesses through its America's Seed Fund initiative, which is part of the Small Business Innovation Research (SBIR) program mandated by Congress. With an operating budget of approximately $7.8 billion, the NSF is committed to advancing fundamental research and education, thus fostering innovation and technological development in the United States.

SOSV, established in 1995 and headquartered in Princeton, New Jersey, is a global venture capital firm specializing in early-stage investments. It focuses on deep tech innovations in the health and environmental sectors, supporting founders with breakthrough technologies through its HAX and IndieBio startup development programs. SOSV provides resources, facilities, and lab equipment to accelerate product development and scale, with a track record of helping its portfolio companies secure subsequent funding rounds led by top-tier investors.

Antler, established in 2017 and headquartered in Singapore, is an early-stage venture capital firm focused on investing in technology companies. It supports exceptional founders from day one, providing access to a global network of co-founders, talent, advisors, and expansion support, along with capital. Antler's funds, including Antler UK Fund and Antler India Fund, target various sectors such as information technology, climate tech, healthtech, software, energy services, and SaaS, with investments ranging from USD 0.2 to 0.4 million.

RA Capital Management is a Boston-based investment advisor founded in 2004, specializing in the life sciences and healthcare sectors. The firm focuses on early-stage companies developing innovative technologies, products, and services in drug development, medical devices, diagnostics, and research tools. With a team of professionals trained in biology, chemistry, and medicine, RA Capital Management leverages its extensive industry and business development experience to identify and invest in promising healthcare ventures. As a Registered Investment Adviser, the firm employs a strategic approach that includes both venture capital investments and a hedge fund strategy, targeting opportunities primarily in the United States and Europe.

Google for Startups is an initiative launched in 2011 that focuses on supporting startups globally by providing access to Google's products, connections, and best practices. The program partners with over fifty leading startup organizations to foster entrepreneurial ecosystems in more than 135 countries. It offers various resources, including financial support and exclusive programming, to help these partners and their startups thrive. Central to this initiative are six Google for Startups Campuses located in London, Tel Aviv, Seoul, Madrid, São Paulo, and Warsaw. These Campuses serve as collaborative spaces where startup founders can access mentorship, educational resources, and networking opportunities within their local communities. Startups benefit from free workspaces, community events, and a network of like-minded entrepreneurs, all aimed at nurturing their growth and innovation across diverse sectors such as healthcare, retail, finance, and technology.

Khosla Impact, established in 2013, is an impact investment firm based in Menlo Park, California. It focuses on assisting high-impact entrepreneurs who develop products and services for the three billion people at the bottom of the world's economic pyramid. The firm invests in for-profit enterprises serving low-income individuals and small businesses in emerging markets, with a primary focus on South Asia. Khosla Impact encourages experimentation and supports entrepreneurs passionate about solving socio-economic challenges through technology and innovative business models.

New Enterprise Associates (NEA) is a prominent venture capital firm established in 1977, headquartered in Menlo Park, California, with additional offices in the U.S., India, and China. NEA specializes in investing in technology and healthcare sectors, with a focus on enterprise, consumer, fintech, life sciences, and digital health companies. The firm engages with entrepreneurs at various stages of business development, providing support from initial funding to public offerings. NEA invests globally, with a significant presence in Asia, including China and India, as well as the United States. The firm typically invests between $0.05 million and $20 million per deal.

Duke Energy is a major utility company based in Charlotte, North Carolina, providing electric and natural gas services to approximately 8.2 million customers across the United States. The company operates regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky, and has roughly 35,000 megawatts of electric generating capacity. In addition to its core services, Duke Energy manages natural gas distribution for over 1.6 million customers in Ohio and Kentucky. The company also owns and operates diverse power generation assets, including a significant portfolio of renewable energy projects in North America and Latin America. Through its efforts, Duke Energy aims to deliver energy in a sustainable manner while contributing to the economic vitality and resilience of the communities it serves.

Perceptive Advisors, established in 1999, is a New York-based investment management firm specializing in the life sciences sector. It invests in both private and public biotechnology, pharmaceutical, medical device, diagnostics, and health services companies across their lifecycle, from seed and early-stage ventures to public equities. The firm employs a long/short equity strategy and conducts in-house research to identify promising opportunities. Perceptive Advisors also offers customized debt financing solutions through its Perceptive Credit Opportunities Fund.

Andreessen Horowitz, established in 2009 by Marc Andreessen and Ben Horowitz, is a prominent venture capital firm based in Menlo Park, California. The company specializes in investing in software businesses, with a focus on sectors such as bio + healthcare, artificial intelligence, consumer, enterprise, fintech, and infrastructure. It typically invests in startups at various stages, from seed to late-stage, with a flexible investment range of $0.025 million to $50 million. The firm is known for its focus on disruptive technology and has raised multiple funds to support its investment strategy.

Right Side Capital Management, established in 2010, is a San Francisco-based venture capital firm that specializes in early-stage technology investments. It focuses on funding pre-seed rounds, making 75-100 investments annually in startups outside major tech hubs, with pre-money valuations typically ranging from $1M to $3M. The firm prefers capital-efficient businesses and aims to provide a swift investment decision, usually within two weeks. Since 2012, RSCM has invested in approximately 200 companies across 19 U.S. states and several international locations, including Canada, Israel, Australia, New Zealand, and Western Europe.

BoxGroup Services, LLC is a venture capital firm based in New York City, founded in 2009. It specializes in early-stage investments, primarily focusing on pre-seed, seed, and early Series A rounds. The firm targets a variety of sectors, including disruptive technology, healthcare, biotech, food, software as a service, e-commerce, and fintech. BoxGroup typically invests between $50,000 and $500,000 in each company, emphasizing a conviction in the founding team and their vision to create category-defining businesses. Although it primarily invests in New York City, Silicon Valley, and Los Angeles, the firm is open to opportunities globally. Notably, BoxGroup does not take board seats or ownership stakes in the companies it supports.

Maverick Ventures, established in 2015, is a San Francisco-based venture capital firm focused on growth-stage investments. It operates as a subsidiary of Maverick Capital, Ltd., a global investment firm with over 30 years of experience. Maverick Ventures specializes in the Healthcare, Technology, and Consumer sectors, with a particular focus on Software/Services, Medical Devices, Biotech/Pharma, and innovative technology startups. The firm typically leads investment rounds, takes board seats, and actively works with management teams to build successful enterprises. Maverick Ventures has funded over 100 companies to date, leveraging the resources of a global firm while maintaining an agile, focused approach.

Enhanced Capital, established in 1999, is a New York-based investment firm managing over $400 million. It specializes in providing flexible equity and debt financing to small and mid-sized businesses, promoting their growth and expansion. The firm's investment approach is practical and tailored, aiming to maximize the growth potential of companies poised for rapid growth. Enhanced Capital also invests in renewable energy, historic real estate rehabilitation, and affordable housing projects, often leveraging federal and state incentive programs.

Qiming Venture Partners, established in 2006, is a leading China-based venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong, and Singapore. It manages multiple funds totaling $9.5 billion, focusing on early and growth-stage investments in the Technology and Consumer (T&C) and Healthcare industries. With a strong track record, over 200 portfolio companies have achieved exits, and over 70 have become unicorns or super unicorns. Qiming Venture Partners USA, founded in 2017, is its affiliate in Cambridge, Massachusetts, specializing in healthcare, therapeutics, and digital health investments. The firm is known for its deep technical expertise, hands-on operational support, and thought leadership in the venture capital industry.

StartUp Health, founded in 2011 and based in San Francisco, is a venture capital investment firm dedicated to improving global health and wellbeing. The firm collaborates with a network of entrepreneurs known as Health Transformers to pursue ambitious health goals, referred to as health moonshots. These include improving access to care, reducing costs, curing diseases, addressing various health issues such as cancer, women's and children's health, nutrition and fitness, brain health, mental health, addiction, longevity, and pandemic response. StartUp Health boasts the largest health innovation portfolio in the world, comprising over 330 companies across 26 countries and six continents. The firm is supported by a diverse range of prominent investors from the healthcare and technology sectors, reflecting its commitment to fostering innovation in health.

Exact Sciences Corporation, based in Madison, Wisconsin, specializes in cancer screening and diagnostic tests. Its primary product, Cologuard, is a non-invasive, stool-based DNA test for detecting colorectal cancer and pre-cancer. The company also offers Oncotype DX, a suite of tissue-based genomic tests for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. Exact Sciences is committed to improving cancer detection and treatment through innovative, patient-friendly solutions.

Flare Capital Partners, established in 2013, is a Boston-based venture capital firm specializing in early-stage investments in healthcare technology. The firm focuses on transformative technologies and services that enable value-based healthcare, with a particular interest in mobile solutions, big data analytics, and secure infrastructure. Flare Capital Partners invests across the United States, recognizing the widespread innovation in healthcare technology across the country.

Casdin Capital is a New York-based investment firm established in 2012, specializing in fundamental research within the life sciences and healthcare sectors. The firm focuses on a range of investments, from early-stage to late-stage private opportunities, and is particularly interested in areas such as oncology, digital health, and agtech. As a Registered Investment Adviser, Casdin Capital employs a long-short equity strategy to manage its portfolio. Founded by Eli Casdin, the firm has built a reputation for its analytical approach to investing in innovative healthcare solutions, aiming to capitalize on advancements in the industry. As of October 2020, Casdin Capital managed approximately $2.2 billion in assets.

Gaingels is a venture investment syndicate founded in 2014 and based in Burlington, Vermont, dedicated to supporting the LGBT+ community and its allies. The organization invests in companies led by LGBT+ founders and executives at all stages of development, as well as in established firms committed to enhancing their diversity and inclusivity. With a global portfolio comprising over 130 companies and $70 million in investment capital deployed, Gaingels plays a vital role in fostering an inclusive business environment. Additionally, the Gaingels network actively assists its portfolio companies in identifying and recruiting diverse talent for their leadership teams, while cultivating a vibrant community of industry leaders, investors, and entrepreneurs committed to driving positive social change through business initiatives.

Foresite Capital, established in 2011, is a San Francisco-based healthcare and life sciences investment firm with approximately $2 billion under management. It takes a data-driven, collaborative approach to investing, providing not just capital but also a multidisciplinary team of experts to support its portfolio companies. Foresite focuses on growth equity investments across the U.S. healthcare sector, with a particular interest in startups that leverage biology, big data, and technology to improve healthcare outcomes. Its portfolio includes companies like 10x Genomics, Relay Therapeutics, and Element Biosciences. The firm aims to address areas of great unmet clinical need and supports promising healthcare and life sciences businesses at all stages of their development.

Polaris Partners, established in 1996 and headquartered in Boston, Massachusetts, is a venture capital firm focusing on healthcare, life sciences, and biotechnology sectors. The firm invests across various stages, from early-stage companies to growth equity, partnering with repeat entrepreneurs and innovators. Polaris' healthcare portfolio spans digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics, while its life sciences and biotechnology investments center around molecules, platforms, therapeutics, and genomics. With offices in Boston and San Francisco, Polaris has a 20-year history of supporting companies that improve people's lives and work.

AlleyCorp, founded in 2007 by entrepreneur Kevin Ryan, operates as a startup studio and venture capital firm based in New York City. The company focuses on creating and nurturing transformational companies, primarily in sectors such as technology, enterprise software, marketplaces, healthcare services, and robotics. AlleyCorp originates business ideas, assembles founding teams, provides initial funding for the first 6 to 12 months, and maintains leadership throughout the companies' development. Since its establishment, AlleyCorp has launched several notable companies, including MongoDB, Business Insider, Gilt Groupe, Zola, Nomad Health, Workframe, and CoEdition, which collectively have raised over $1 billion in funding and achieved an aggregate valuation of $10 billion. Additionally, AlleyCorp invests in early-stage companies, often serving as the first seed investor and supporting first-time founders in their entrepreneurial journeys.

IndieBio, established in 2014, is a San Francisco-based accelerator firm specializing in Synthetic Biology. It runs intensive four-month programs for early-stage companies and teams with innovative biological concepts. IndieBio invests in seed and early-stage startups globally, focusing on those that use biology as their core technology to solve real-world problems. The firm typically invests $250k, with an initial cash investment of $50k in exchange for an 8% equity stake. It prefers teams with at least two co-founders. IndieBio was the world's first accelerator dedicated to biology-based startups, aiming to address global challenges through innovative biotechnology.

Frist Cressey Ventures, established in 2016 and headquartered in Nashville, Tennessee, is a venture capital firm specializing in early and growth-stage healthcare companies. It invests in technology and service businesses that enhance care quality, system integration, patient outcomes, and population health. The firm partners with entrepreneurs who share its core values, aiming to accelerate growth and improve healthcare through value-added collaborations.

CVS Health Corporation is a diversified healthcare company that provides a range of services and plans in the United States. It operates through three primary segments: Pharmacy Services, Retail/LTC, and Health Care Benefits. The Pharmacy Services segment offers management solutions for prescription drug plans, including mail order and specialty pharmacy services, as well as clinical and disease management programs. This segment serves various clients such as employers, health plans, and individuals. The Retail/LTC segment sells prescription and over-the-counter drugs, personal care products, and provides healthcare services through MinuteClinic walk-in medical clinics. It also distributes drugs and provides related services to long-term care facilities. As of 2019, CVS Health operated approximately 9,900 retail locations and 1,100 MinuteClinic locations. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services to employer groups, individuals, and other entities. CVS Health was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

Everywhere Ventures, established in 2017 and based in New York, is a unique early-stage venture fund created by founders for founders. It invests globally in pre-seed deals, typically in a company's first financing round. The fund, with over $70 million under management, is backed by over 500 founders and operators who serve as its limited partners. Everywhere Ventures focuses on purpose-driven teams in the money, health, and work verticals, providing not just capital, but also the expertise and mentoring of its experienced limited partners.

Oak HC/FT, established in 2014 and based in Stamford, Connecticut, is a leading venture and growth equity investment firm. It specializes in healthcare information services and financial service technology, focusing on driving industry transformation by providing strategic counsel, board-level participation, and access to an extensive network of industry leaders to entrepreneurs and companies. Over the past decade, Oak HC/FT's partners have facilitated 29 realizations, including four IPOs and six companies valued over $1 billion. The firm manages multiple funds, investing between $5 million and $50 million in growth-stage companies and up to $35 million in earlier-stage ventures across the United States and Europe.

Town Hall Ventures, established in 2018 and headquartered in New York, is a venture capital firm dedicated to transforming the U.S. healthcare market through technology. It invests in and supports visionary entrepreneurs focused on improving care delivery and health outcomes for underserved and higher need populations. The firm primarily targets series A and B investments in healthcare technology companies across the United States, aiming to drive higher quality and more affordable care for vulnerable Americans.

F-Prime Capital is a venture capital firm established in 1969 and headquartered in Cambridge, Massachusetts, with additional offices in San Francisco and London. It is part of the Fidelity Investments family, which has a long history of supporting entrepreneurs. F-Prime Capital focuses its investments on companies in North America and Europe, specializing in sectors such as healthcare, life sciences, therapeutics, fashion, medtech, health information technology and services, and technology. The firm emphasizes a hands-on approach, leveraging its deep industry expertise and extensive relationships to assist entrepreneurs in building significant companies. F-Prime Capital operates without the pressures of external fundraising, allowing it to concentrate on identifying and nurturing promising ventures.

City Light Capital, established in 2004, is a New York-based venture capital firm specializing in early-stage investments. It focuses on impactful companies operating in sectors such as education, technology, healthcare, clean tech, and agriculture, primarily within the United States. City Light partners with experienced teams developing innovative solutions that positively impact lives at scale, with a proven track record in building successful companies. Notable portfolio investments include 2U, ShotSpotter, Trilogy Education, and Ready Responders.

The European Innovation Council (EIC), established in 2020 and headquartered in Brussels, Belgium, is dedicated to supporting high-potential innovators, entrepreneurs, small enterprises, and researchers. Its primary focus is on fostering early-stage startups that demonstrate significant environmental, social, and governance (ESG) impacts. The EIC collaborates with private investors to co-invest in ventures, particularly within the deep technology sector, aiming to drive innovation and sustainable development across Europe. By providing financial backing and resources, the EIC seeks to enhance the growth potential of promising startups and contribute to a more innovative and competitive European economy.

Liquid 2 Ventures, established in 2015, is a San Francisco-based venture capital firm. It specializes in seed-stage investments, focusing on early-stage technology companies, particularly in the software and TMT sectors. The firm, founded by Joe Montana, Mike Miller, and Michael Ma, aims to support and nurture startups during their initial growth phases.

First Round Capital, established in 2004, is a San Francisco-based venture capital firm specializing in seed-stage investments. It focuses on building a robust community of technology entrepreneurs and companies, providing custom software solutions, in-person experiences, and unique services to help early-stage companies grow. First Round Capital has invested in notable startups like Uber, Square, and Warby Parker, and has adopted the Diversity Term Sheet Rider to promote diversity in its portfolio. The firm invests nationally, with additional offices in San Francisco and New York, typically providing around $500,000 in the initial investment. It actively supports its portfolio companies and has facilitated a VC-sponsored exchange fund for qualified entrepreneurs. To date, members of the First Round Capital community have raised over $2.5 billion in follow-on capital.

CareSource is a nonprofit managed care organization headquartered in Dayton, Ohio, with additional offices in Hilliard and Mayfield Heights, Ohio, Louisville, Kentucky, and Indianapolis, Indiana. Founded in 1989, it is one of the largest Medicaid managed health care providers in the United States, offering plans to members in Ohio, Kentucky, and Indiana. CareSource is committed to enhancing the health and well-being of its members, aiming to make a significant impact on their lives through its services. As a subsidiary of CareSource Management Group Company, it focuses on delivering quality care and support to its communities.

High-Tech Gründerfonds Management GmbH is a venture capital firm based in Bonn, Germany, specializing in early-stage investments in high-tech startups. Established in 2005, the firm focuses on technology-driven companies across various sectors, including information and communication technology, life sciences, healthcare, automation, and cleantech. HTGF typically invests in companies that have been operational for no more than one year, aiming to contribute up to €0.6 million in initial funding and up to €3 million in follow-on financing. The firm seeks a minority stake, generally around 15%, and provides a subordinated loan convertible into equity, with deferred interest for up to four years to support liquidity. With a total investment volume of approximately €895.5 million across three funds, HTGF has successfully supported over 500 startups and attracted more than €2 billion in follow-on investments from external sources. The firm's investors include notable public and private entities, underscoring its role as a key player in fostering innovation and growth within the German startup ecosystem.

Echo Health Ventures is a venture capital firm established in 2016, with offices in Durham, Portland, and Seattle. The firm specializes in investing in healthcare companies, aiming to accelerate their innovations for national scalability. Echo Health Ventures takes a stage-agnostic approach to investing, seeking to build deep, high-value relationships with portfolio companies beyond just providing capital. This commitment to fostering collaboration helps drive the growth and success of the healthcare startups in which they invest.

Novartis is a global healthcare company headquartered in Switzerland, dedicated to addressing evolving patient needs worldwide. It operates through several divisions: Novartis Pharmaceuticals for innovative medicines, Sandoz for generics and biosimilars, and Alcon for eye care devices. The company focuses on key therapeutic areas such as oncology, rare diseases, neuroscience, immunology, respiratory, and cardio-metabolic diseases. Novartis also invests in early-stage life sciences and biotechnology companies through its venture capital arm, Novartis Venture Fund, seeking innovative therapeutics, medical devices, diagnostics, and drug delivery systems. Additionally, Novartis Animal Health develops products for pets, farm animals, and farmed fish, contributing to animal health and welfare. The company's research and development efforts are supported by the Genomics Institute of the Novartis Research Foundation, which bridges basic science and preclinical drug discovery.

Versant Ventures, established in 1999, is a global healthcare investment firm headquartered in San Francisco, California. With over $2.3 billion under management and offices in North America and Europe, the firm invests across the healthcare sector, with a focus on discovering and developing novel therapeutics. Versant's team, comprising deep investment, operating, and scientific expertise, takes a hands-on approach to company building. Since inception, over 65 Versant companies have achieved successful acquisitions or IPOs.

Help at Home is a home care agency dedicated to improving the quality of life for seniors and individuals with disabilities. The company specializes in providing personalized care services, enabling clients to maintain independence and dignity in their own homes. Help at Home is committed to being a quality employer, offering competitive compensation and benefits to attract and retain the best staff. Their services provide a viable alternative to living in a nursing home or long-term care facility.

Novo Holdings, established in 1999, is a Danish asset management firm based in Copenhagen. It serves as the investment arm of the Novo Nordisk Foundation, managing its assets and wealth. The company's primary focus is the life science sector, with a diversified portfolio comprising equities, bonds, real estate, infrastructure, and private investments. Novo Holdings maintains a significant influence on Novo Nordisk A/S and Novozymes A/S, ensuring these companies align with the Novo Group's visions and values. It also invests in early and growth-stage life science companies through its venture capital arm, Novo Ventures, which targets investments ranging from USD 5 million to USD 30 million.

8VC, established in 1969 and headquartered in San Francisco, is a venture capital firm that invests in early-stage companies across various sectors, with a focus on enabling industry transformation. The firm, which is a Registered Investment Adviser, partners with founders to develop transformational technologies, targeting sectors such as healthcare, logistics, biology, IT infrastructure, and government & defense. 8VC aims to create long-term economic and societal value through its investments, promoting innovation and global prosperity.

Invus Financial Advisors, LLC is an employee-owned investment firm based in New York, founded in 2006. The firm specializes in private equity investments and manages pooled investment vehicles, including hedge funds and funds of funds. Invus focuses on making direct and indirect investments in special situations, venture capital, and growth equity stages, with an emphasis on smaller companies and opportunistic co-investments. The firm adopts a flexible approach, recognizing the uniqueness of each company and the complexities of business transformation. Invus maintains a long-term commitment to its investments, aligning its incentives with those of its partners. With a history of empowering owner-managers since 1985 and a strong backing from a group of European families, Invus Financial Advisors manages over $4 billion in an evergreen fund and operates additional offices in London, Paris, and Hong Kong.

Venrock, established in 1969, is a venture capital firm headquartered in Palo Alto, California, with additional offices in New York. It specializes in seed and early-stage investments, primarily in technology and healthcare sectors. The firm partners with entrepreneurs to build successful, enduring companies, with a notable track record including Apple, Athenahealth, and Gilead Sciences. Venrock also manages dedicated funds for healthcare investments, such as Venrock Healthcare Capital Partners, focusing on both private and public biotechnology companies.